News

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31

Flightpath participates in the “New Commitment to Patients” to Ensure Access and Act with Integrity and Responsibility

Chronic Lyme Disease: An Evidence Based Definition

PUBLICATIONS

March 2, 2020

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31

Venkata Raveendra Pothineni, Hari-Hara S. K. Potula, Aditya Ambati,
Venkata Vamsee Aditya Mallajosyula, Brindha Sridharan, Mohammed Inayathullah, Mohamed Sohail Ahmed, and Jayakumar Rajadas

VIEW PDF

May 30, 2019

Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases

By Kenneth Liegner

VIEW PDF

December 16, 2019

Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group

By Samuel Shor, Christine Green, Beatrice Szantyr, Steven Philips, Kenneth Liegner, Joseph Burrascano Jr., Robert Bransfield, Elizabeth L. Maloney

VIEW PDF

NEW
05-28-2020

Elizabeth L. Maloney, MD Publishes on Reducing the Burden of Lyme Disease

NEW
05-26-2020

Baking Soda Fights AutoImmune Disease | NaturalHealth365

NEW
05-22-2020

LDA President Talks Lyme/TBD on PA Radio

NEW
05-21-2020

Johns Hopkins’ Aucott Makes Case for Chronic Lyme Disease

NEW
05-13-2020

Study on Deer Tick Questing for a Host

NEW
05-07-2020

Lyme Disease Vaccine Collaboration Announced

We would like to collect information during your visit to help us better understand site use. This data is anonymized, and will not be used for marketing purposes. Read More on our Privacy Policy page. You can withdraw permission at any time or update your privacy settings here. Please choose below to continue.